Influenza Virus Vaccine Q Code: Q2038
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
Drug & Product Overview
About Influenza Virus Vaccine
Influenza Virus Vaccine is a medication aligned to the HCPCS Q Code: Q2038 for billing, pricing, and reimbursement purposes in the United States. Classified under Vaccine, it is administered via the intramuscular route and manufactured by Sanofi.
Manufacturers, reach out to us to add more information.
NDC Code Information
6 NDC packages are crosswalked to Q2038. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | Influenza Virus Vaccine | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | Influenza Virus Vaccine | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | Influenza Virus Vaccine | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | Influenza Virus Vaccine | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
Influenza Virus Vaccine CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid) |
| 90472 | Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure. |
CMS does not include Influenza Virus Vaccine (Q2038) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2038. Wastage billing guide →
Influenza Virus Vaccine Medically Unlikely Edits (MUE)
The most billing units of Q2038 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per therapeutic dose.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
Influenza Virus Vaccine Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Influenza Virus Vaccine billing and coding guide?
Are there any available Influenza Virus Vaccine patient assistance programs?
Where can I find Influenza Virus Vaccine prescribing information?
Where can I find Influenza Virus Vaccine side effect information?
Does billing Influenza Virus Vaccine require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Influenza Virus Vaccine.
